Patient Square Capital LP Diversified Active

CIK: 0001819257 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 10, 2025

Total Value ($000): $373,857 (100.0% shares, 0.0% debt)

Holdings (24)

ROIV ROIVANT SCIENCES LTD 50.5%
Value ($000) $188,822 Shares 12,480,000 Est. Cost $7.21 Unrealized +71.6%
INSM INSMED INC 12.6%
Value ($000) $47,005 Shares 326,400 Est. Cost $73.51 Unrealized +66.6%
EYPT EYEPOINT PHARMACEUTICALS INC 3.9%
Value ($000) $14,409 Shares 1,011,839 Est. Cost $8.71 Unrealized +32.1%
ABVX ABIVAX SA 3.4%
Value ($000) $12,891 Shares 151,833 Est. Cost $84.90 Unrealized
CIDARA THERAPEUTICS INC 3.1%
Value ($000) $11,587 Shares 121,000 Est. Cost $89.93 Unrealized
ARGX ARGENX SE 3.1%
Value ($000) $11,432 Shares 15,500 Est. Cost $551.22 Unrealized
LQDA LIQUIDIA CORPORATION 2.4%
Value ($000) $9,096 Shares 400,000 Est. Cost $13.90 Unrealized +56.0%
PHVS PHARVARIS N V 2.3%
Value ($000) $8,617 Shares 345,381 Est. Cost $19.26 Unrealized +15.1%
OCUL OCULAR THERAPEUTIX INC 2.2%
Value ($000) $8,358 Shares 715,000 Est. Cost $8.36 Unrealized +43.1%
MIRM MIRUM PHARMACEUTICALS INC 2.0%
Value ($000) $7,643 Shares 104,262 Est. Cost $44.09 Unrealized +44.2%
AGIO AGIOS PHARMACEUTICALS INC 1.4%
Value ($000) $5,372 Shares 133,827 Est. Cost $45.20 Unrealized -16.8%
KYMR KYMERA THERAPEUTICS INC 1.4%
Value ($000) $5,241 Shares 92,592 Est. Cost $36.45 Unrealized +23.7%
ELVN ENLIVEN THERAPEUTICS INC 1.4%
Value ($000) $5,135 Shares 250,838 Est. Cost $24.33 Unrealized -17.2%
CELC CELCUITY INC 1.3%
Value ($000) $4,940 Shares 100,000 Est. Cost $40.03 Unrealized 0.0%
DNTH DIANTHUS THERAPEUTICS INC 1.3%
Value ($000) $4,919 Shares 125,000 Est. Cost $25.56 Unrealized 0.0%
IRON DISC MEDICINE INC 1.3%
Value ($000) $4,890 Shares 74,000 Est. Cost $57.12 Unrealized +4.1%
QURE UNIQURE NV 1.2%
Value ($000) $4,378 Shares 75,000 Est. Cost $18.16 Unrealized 0.0%
AMLX AMYLYX PHARMACEUTICALS INC 1.1%
Value ($000) $4,299 Shares 316,312 Est. Cost $9.41 Unrealized 0.0%
NRIX NURIX THERAPEUTICS INC 1.1%
Value ($000) $4,040 Shares 437,237 Est. Cost $22.02 Unrealized -52.8%
ALLO ALLOGENE THERAPEUTICS INC 1.0%
Value ($000) $3,697 Shares 2,981,396 Est. Cost $2.05 Unrealized -41.7%
ASMB ASSEMBLY BIOSCIENCES INC 0.9%
Value ($000) $3,461 Shares 135,182 Est. Cost $21.94 Unrealized 0.0%
AVTX AVALO THERAPEUTICS INC 0.3%
Value ($000) $1,271 Shares 100,000 Est. Cost $8.60 Unrealized 0.0%
CATX PERSPECTIVE THERAPEUTICS INC 0.3%
Value ($000) $1,198 Shares 349,323 Est. Cost $3.65 Unrealized 0.0%
GERN GERON CORP 0.3%
Value ($000) $1,158 Shares 845,000 Est. Cost $1.40 Unrealized -5.2%